{"id":"NCT00310466","sponsor":"ALK-Abell√≥ A/S","briefTitle":"Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever","officialTitle":"A Multicentre, Randomised, Double-blind, Placebo-controlled Parallel Group Clinical Trial to Investigate the Efficacy and Safety of Specific Sublingual Immunotherapy With SLITone Birch in Patients With Seasonal Birch Pollen Induced Rhinoconjunctivitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-06","primaryCompletion":"2006-08","completion":"2007-01","firstPosted":"2006-04-04","resultsPosted":"2009-08-06","lastUpdate":"2013-05-14"},"enrollment":226,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Allergy"],"interventions":[{"type":"BIOLOGICAL","name":"Sublingual immunotherapy","otherNames":["SLITone(TM) Birch"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sublingual immunotherapy","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The trial is performed to assess the efficacy and safety of SLIT One birch for treatment of birch pollen induced allergy","primaryOutcome":{"measure":"Daily Rhinoconjunctivitis Symptom Score","timeFrame":"Birch pollen season 2006","effectByArm":[{"arm":"SLITone Birch","deltaMin":4.07,"sd":2.59},{"arm":"Placebo","deltaMin":4.14,"sd":2.56}],"pValues":[{"comp":"OG000 vs OG001","p":"0.87"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":113},"commonTop":["Oral pruritus","Nasopharyngitis","Paraesthesia oral","Oral discomfort","Eye pruritus"]}}